AI assistant
CORCEPT THERAPEUTICS INC — Director's Dealing 2017
Nov 15, 2017
30681_dirs_2017-11-15_c68cec7a-da3e-453c-9650-7c6c7912090c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-11-13
Reporting Person: BAKER G LEONARD JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-13 | Common Stock | M | 30000.0000 | $2.7000 | Acquired | 806838.0000 | Direct |
| 2017-11-13 | Common Stock | S | 30000.0000 | $17.5852 | Disposed | 776838.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-13 | Stock Option (Right To Buy) | $2.7000 | M | 30000.0000 | Disposed | 2017-12-19 | Common Stock (30000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2613634.0000 | Indirect |
| Common Stock | 955055.0000 | Indirect |
Footnotes
F1: The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.55 to $17.65, inclusive. The reporting person undertakes to provide to Corcept Therapeutics Incorporated, and any security holder of Corcept Therapeutics Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
F4: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.